Invesaro

Stocks EXLS Financial statements

Financial statements

ExlService Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ExlService Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue6867628839919581,1221,4121,6311,8382,088
Cost of revenue4484965856556246918971,0231,1471,287
Gross profit238267298336334431515608691801
Selling and marketing50.653.463.671.860.184.398120147173
General and administrative88.6103116127114142169198226255
Operating expenses174194248259224275323369427487
Operating income64.572.749.876.5110156192239264314
Interest expense1.341.897.2313.611.27.568.2513.219.317.6
Interest income1.671.631.872.182.52.735.238.039.929.64
Other non-operating income19.412.310.56.655.31-9.32-2.06-0.81-2.271.3
Pre-tax income83.98560.483.1115147190238261315
Income tax22.236.13.415.225.631.947.653.562.963.7
Net income61.748.956.767.789.5115143185198251
EBITDA99.111298.5129161206248289319373
EPS, basic0.370.290.330.390.520.680.861.111.221.56
EPS, diluted0.360.280.320.390.520.670.851.101.211.54
Shares, basic (weighted)168169172172171168167166163161
Shares, diluted (weighted)173176175174173171169168164162

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents21386.895.9119219135119137153146
Short-term investments13.5178184202184179179154187182
Receivables113136165172148194259308304343
Other current assets21.229.628.224.637.1635176.7140146
Total current assets379453500541609578613680795830
Property, plant and equipment4966.873.579.192.485.782.399.6100112
Lease right-of-use assets86.491.976.755.364.968.897.4
Goodwill187204350350349404406406420420
Intangible assets53.84995.57459.681.164.850.249.336.2
Long-term investments3.1934.84.43148.2
Other non-current assets19.936.4313632.130.232.149.556.161.8
Total assets7078251,0621,1831,2481,2831,3461,4421,6181,702
Accounts payable3.295.925.656.566.995.657.795.065.884.75
Accrued liabilities43.361.464.27466.476.495.4114114135
Deferred revenue16.610.77.7213.432.62018.812.319.315.4
Short-term debt1010.321.440.92526030654.894.89
Total current liabilities124144155229221496278326290324
Long-term debt3550.42631942020220135284294
Lease liabilities074.784.968.548.258.259.988.2
Other non-current liabilities1.142.416.512.118.124.641.331.553.681.4
Total liabilities174225444513529590588553689790
Total debt450.71302235227260250200288299
Paid-in capital285322364391421396445508589678
Retained earnings3834274845526417568991,0841,2821,533
Treasury stock-60.4-104-147-188-268-369-442-575-786-1,117
Other comprehensive income-75.1-45.7-83.5-84.9-75-89.5-144-127-155-181
Shareholders' equity532600618670719693758889930913
Minority interests0.190.220.250
Total equity532600618670719693758889930913
Total liabilities and equity7078251,0621,1831,2481,2831,3461,4421,6181,702
Shares outstanding16816917117116833.3166165162156

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income61.748.956.767.789.5115143185198251
Depreciation and amortization34.63948.752.250.549.756.150.355.259.2
Stock-based compensation19.82323.926.128.238.649.458.472.779.5
Deferred income tax-3.380.73-0.63-12.32.7-20.3-19.6-31.7-19.9-15.1
Change in receivables-18.1-20.5-10-7.0924.7-37.7-68.1-49.24.65-36
Change in payables-2.631.71-0.360.130.24-0.612.39-2.7620.511.2
Cash from operations10211392.4168203184166211269351
Capital expenditures-25.9-35.2-40.8-40.5-42.2-37.2-44.8-52.8-46.3-52.6
Acquisitions-28.7-23.3-23200-76.8-3.870-24.30
Purchases of investments-182-403-133-188-102-96-213-235-289-314
Sales and maturities of investments18224112817712694.5165276241318
Cash from investing-54.7-223-277-51.4-18.3-114-96.5-12-119-49.3
Debt issued060.62473580290235
Debt repaid-25-45.2-155-98.2-121-329-45-130-201-225
Stock issued6.58.561.40.991.50.711.065.575.026.24
Share buybacks-18.2-43.5-43.1-41.4-79.9-118-72.6-132-208-328
Cash from financing-32.7-20.5198-93.1-89.6-147-81.7-181-119-313
Exchange rate effect-5.123.94-2.87-1.053.38-4.95-6.062.03-4.335.88
Net change in cash9.88-1269.8522.998.5-81.7-18.219.826-5.43
Free cash flow76.57851.6128161147121158222298
Interest paid1.181.124.7310.67.636.598.1913.919.617
Income taxes paid15.719.118.519.120.65057.110710977.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $34.75 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin38.5%Gross profit / revenue.
Operating margin15.2%Operating income / revenue.
EBITDA margin17.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin15.1%Pre-tax income / revenue.
Net margin11.7%Net income / revenue.
FCF margin13.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin16.2%Cash from operations / revenue.
Effective tax rate22.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)32.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)15.0%Net income / average total assets.
Return on invested capital (ROIC)24.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue3.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.4%Capital expenditures / revenue.
D&A / revenue2.8%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y13.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y13.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y16.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y15.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y15.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y19.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y19.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y17.8%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y23.3%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y17.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y14.5%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y18.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y26.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y20.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y22.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y27.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y21.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y24.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y30.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y28.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y11.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y34.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y34.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y13.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-1.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y5.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y6.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.66xCurrent assets / current liabilities.
Quick ratio2.14x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.85x(Cash + short-term investments) / current liabilities.
Debt / equity0.54xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets24.9%Total debt / total assets.
Liabilities / assets53.5%Total liabilities / total assets.
Net debt$163.6MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.42xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage18.8xOperating income / interest expense.
Working capital$497.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets26.9%(Goodwill + intangible assets) / total assets.
Tangible book value$327.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.29xRevenue / average total assets.
Fixed asset turnover19.7xRevenue / average property, plant and equipment.
Receivables turnover5.55xRevenue / average receivables.
Days sales outstanding66 days365 x average receivables / revenue.
Days payables3 days365 x average accounts payable / cost of revenue.
FCF conversion117.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow15.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.60Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$13.75Revenue / diluted weighted shares.
FCF per share$1.89Free cash flow / diluted weighted shares.
Operating cash flow per share$2.23Cash from operations / diluted weighted shares.
Book value per share$5.09Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.14Tangible book value / shares outstanding.
Cash per share$1.66(Cash + short-term investments) / shares outstanding.
Buybacks / FCF160.6%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$5.27BShare price x shares outstanding.
Enterprise value$5.43BMarket cap + total debt - cash - short-term investments.
P/E20.9xMarket cap / net income. Only when net income is positive.
P/S2.44xMarket cap / revenue.
P/B6.76xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book16.1xMarket cap / tangible book value, when positive.
P/FCF17.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.1xMarket cap / cash from operations, when positive.
EV/Sales2.52xEnterprise value / revenue.
EV/EBIT16.6xEnterprise value / operating income, when both are positive.
EV/EBITDA14.0xEnterprise value / EBITDA, when both are positive.
EV/FCF18.3xEnterprise value / free cash flow, when both are positive.
FCF yield5.6%Free cash flow / market cap.
Earnings yield4.8%Net income / market cap (the inverse of P/E).
Shareholder yield9.0%(Dividends paid + share buybacks) / market cap.
PEG0.96xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was ExlService Holdings, Inc.'s revenue in fiscal 2025?

ExlService Holdings, Inc. reported revenue of $2.09B for fiscal 2025, 13.6% higher than the year before.

Was ExlService Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $251.0M, a net margin of 12%.

How much free cash flow did ExlService Holdings, Inc. generate in fiscal 2025?

Cash from operations of $350.7M minus capital expenditures of $52.6M left free cash flow of $298.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ExlService Holdings, Inc.